← Back to VTS Methodology
VTS Scoring Log

Ion Peptides

ionpeptide.com · Est. 2025 · Peachtree Corners, GA · Scored August 2026

Ion Peptides names Freedom Diagnostics (Tennessee) as its testing lab and runs four analytical methods per batch: NMR, HPLC, LC-MS, and GC-MS. A public COA library at ionpeptide.com/lab-results/ is searchable by product and batch number without login. Freedom Diagnostics maintains its own public archive of 15,000+ COAs independently searchable by accession number - the same lab PeptideClear uses for COA cross-verification on other vendors - meaning Ion Peptide COAs can be verified against a source the vendor does not control. The score is held from the High band by a single factor: Ion Peptides was established in 2025 and has less than one year of documented operation at time of scoring.

78 /100
Moderate
Named lab (Freedom Diagnostics), 4-method testing, publicly searchable COA library with independent cross-verification path. Held from High band by sub-1-year operational track record and dual-entity structure with no public explanation.
Dimension Scores
Dimension Max Notes Score
Third-Party Testing Practice 30 Freedom Diagnostics (Tennessee) named as testing lab. Four analytical methods documented: NMR, HPLC, LC-MS, and GC-MS. Full HPLC chromatograms included on COAs - not summary purity percentages only. Per-batch testing confirmed with lot-specific documentation. Freedom Diagnostics is independently verifiable and maintains its own public COA archive, providing a cross-check path outside the vendor's control. Minor deduction for absence of sterility and endotoxin data in the standard panel. 26/30
Batch Traceability & Verification 20 Lot-specific COAs confirmed. COA library at ionpeptide.com/lab-results/ is searchable by product and batch number without account creation. Physical return address published (Ion Research, 5834 Peachtree Corners E, Suite C, Peachtree Corners, GA 30092) providing a verifiable business anchor for lot-level accountability. Minor deduction for dual-entity structure: published sources identify both Great Research LLC (New Mexico) and Ion Research (Georgia) associated with this vendor, with no public explanation of the relationship. 17/20
COA Accessibility 15 Public COA library accessible at /lab-results/ without login or account creation. Batch search by product or lot number. Freedom Diagnostics accession numbers are independently verifiable on Freedom's own public platform - a second verification layer that does not route through the vendor's hosted copies. 13/15
COA Completeness 15 HPLC (purity) and mass spectrometry (identity) confirmed across documented batches. NMR and GC-MS also cited. Full chromatogram data present. No publicly documented sterility or endotoxin testing in the standard panel, which limits the score relative to vendors running broader contaminant screens. 10/15
Testing Recency 10 Vendor launched 2025; all published COAs are recent by definition. COA library updated through August 2026. No evidence of stale documentation being reused across product SKUs. 8/10
Policy Transparency 5 Dedicated refund policy page at /refund-policy/ with specific terms: 30-day window, unopened items, 5-7 business day processing, damaged item claims within 48 hours. Physical address and return address publicly published. Minor deduction for dual-entity ambiguity with no public explanation. 3/5
Operational Track Record 5 Domain registered approximately mid-2025. Less than one year of documented operation at time of scoring. 100+ product catalog assembled, which is notable for a young operation, but track record is too short to carry meaningful weight. Trustpilot 3.7/5 across 27 reviews; bimodal split with negative reviews appearing to involve impersonator accounts per community reporting, not the vendor itself. 1/5
Total 78/100
Community Signal
Independent Test Results
No community-commissioned independent test results identified in public forums as of August 2026. One reviewer flagged a batch of Ion's retatrutide product as ineffective - a reminder to verify the COA accession for a specific lot. This field will be updated as independently sourced results are published.
Community Experience
Positive reviews cite fast shipping, premium packaging, and responsive support. A subset of negative Trustpilot reviews reference post-order spam emails and checkout concerns; root cause is unconfirmed and community reporting suggests overlap with fake impersonator accounts rather than the vendor itself. Using a virtual card on a first order is reasonable general hygiene for a newer vendor regardless of the fraud reports' origin.
Scoring Notes
Documentation quality is mature for a vendor this new
Four-method analytical testing via a named, publicly verifiable US lab is a standard that most vendors with much longer track records do not meet. The Freedom Diagnostics independent archive means Ion Peptide COA accession numbers can be checked against a database the vendor does not own or control - a verification path available on very few entries in this catalog.
Age is the primary score constraint
If Ion Peptide's documentation practices hold through 2026-2027, the Operational Track Record dimension will improve materially and the score would move into the High Transparency band. VTS reflects what is verifiable today, not projected trajectory.
Dual-entity structure worth monitoring
Published sources identify two separate LLC registrations associated with this vendor - Great Research LLC (New Mexico) and Ion Research (Georgia). The return policy and physical documentation reference Ion Research. No public explanation of the dual structure appears on the vendor's site. This is not a disqualifying finding but it is a transparency gap worth tracking.
Sources: ionpeptide.com/lab-results/, ionpeptide.com/refund-policy/, ionpeptide.com/about-us/, ionpeptide.com/return/. VTS measures process transparency from publicly available materials only. It is not a certification of product safety, purity, or efficacy. PeptideClear has no affiliate, referral, or commercial relationship with Ion Peptides. Scored August 2026 - reviewed on a rolling basis as vendor practices change.